Further evidence of the limitations of Activated Partial Thromboplastin Time to monitor Argatroban

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 4, 2018-02 ,pp. : 594-597

John Wiley & Sons Inc

Access to resources Recommend Favorite

Influence of Fibrinogen Degradation Products on Thrombin Time, Activated Partial Thromboplastin Time and Prothrombin Time of Canine Plasma

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 30, Iss. 3, 2000-09 ,pp. : 123-130

Karger

Access to resources Recommend Favorite

Multiple Intracranial Hemorrhages at the Time of a Transiently Prolonged Activated Partial Thromboplastin Time in an Infant with Congenital Factor VII Deficiency

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 1, 1999-01 ,pp. : 14-16

Karger

Access to resources Recommend Favorite

Bartonella henselae: Association with the Development of Transient Lupus Anticoagulant and Asymptomatic Prolongation of Activated Partial Thromboplastin Time

By Economou Marina   Lithoxopoulou Maria   Aivazis Victor   Tsakalidis Christos   Athanassiou-metaxa Miranda  

Scandinavian Journal of Infectious Diseases, Vol. 35, Iss. 2, 2003-01 ,pp. : 149-149

Informa Healthcare

Access to resources Recommend Favorite

Transient Lupus Anticoagulant and Prolonged Activated Partial Thromboplastin Time Secondary to Epstein–Barr Virus Infection

By Shiomou Katerina   Galanakis Emmanouil   Tzoufi Meropi   Tsaousi Christin   Papadopoulou Zoe L.  

Scandinavian Journal of Infectious Diseases, Vol. 34, Iss. 1, 2002-01 ,pp. : 67-69

Informa Healthcare

Access to resources Recommend Favorite